title: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
abstract: The aim of the present study was to characterise the ability of malignant chondrosarcomas to invade normal bone by analysing their production of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). For this purpose 12 chondrosarcomas were investigated for the expression of mRNAs for several MMPs and all 4 TIMPs by Northern hybridisation, and for immunohistochemical localisation of the proteins. A characteristic finding of these analyses was increased expression of MMP-13, MMP-14 and TIMP-2 mRNAs in chondrosarcomas when compared with nonmalignant control samples. Individual chondrosarcomas also exhibited elevated levels of MMP-1, MMP-7 and MMP-9 mRNAs. The results of Northern hybridisations were supported by immunohistochemical stainings of the corresponding tumour areas for MMP-2, MMP-14 and TIMP-2, further suggesting that these may have prognostic value for determining whether individual chondrosarcomas are locally aggressive or have a probability of recurrence. Another finding of the present study was a marked heterogeneity in histologic appearance and gene expression of the chondrosarcomas, emphasising the importance of analysing several areas of these tumours to get representative results. These findings suggest that analysis of MMPs could be a useful diagnostic indicator in patients with cartilaginous tumours and could help in differentiating between a low-grade malignant chondrosarcoma and a benign growing enchondroma.
authors.affiliation: Department of Medical Biochemistry and Molecular Biology, University of Turku, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Söderström
authors.forename: H T
authors.initials: HT
authors.lastname: Aro
authors.forename: M
authors.initials: M
authors.lastname: Ahonen
authors.forename: N
authors.initials: N
authors.lastname: Johansson
authors.forename: A
authors.initials: A
authors.lastname: Aho
authors.forename: T
authors.initials: T
authors.lastname: Ekfors
authors.forename: T
authors.initials: T
authors.lastname: Böhling
authors.forename: V M
authors.initials: VM
authors.lastname: Kähäri
authors.forename: E
authors.initials: E
authors.lastname: Vuorio
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015152:Blotting, Northern; D001859:Bone Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism*; D016022:Case-Control Studies; D002813:Chondrosarcoma / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D020782:Matrix Metalloproteinases / Q000235:genetics* / Q000378:metabolism*; D008875:Middle Aged; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D019714:Tissue Inhibitor of Metalloproteinases / Q000235:genetics* / Q000378:metabolism*
chemical_list: D012333:RNA, Messenger; D012334:RNA, Neoplasm; D019714:Tissue Inhibitor of Metalloproteinases; D020782:Matrix Metalloproteinases